Pediatrics

Positive trial results for RSV infant treatment: Sanofi

French pharmaceutical giant Sanofi announced trial results on Friday that showed its preventative treatment for respiratory syncytial virus (RSV) reduced the rate of babies being hospitalized by more than 80 percent.

Vaccination

Report: Flu vaccine effective for 2022/2023 season

During the 2022 to 2023 influenza season, vaccination is effective for reducing the risk for medically attended influenza among children and adults aged younger than 65 years and for symptomatic influenza among children, ...

page 4 from 34